» Articles » PMID: 34778084

Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Nov 15
PMID 34778084
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC), being one of the most commonly diagnosed cancers worldwide, endangers human health. Because the pathological mechanism of CRC is not fully understood, there are many challenges in the prevention, diagnosis, and treatment of this disease. Long non-coding RNAs (lncRNAs) have recently drawn great attention for their potential roles in the different stages of CRC formation, invasion, and progression, including regulation of molecular signaling pathways, apoptosis, autophagy, angiogenesis, tumor metabolism, immunological responses, cell cycle, and epithelial-mesenchymal transition (EMT). This review aims to discuss the potential mechanisms of several oncogenic lncRNAs, as well as several suppressor lncRNAs, in CRC occurrence and development to aid in the discovery of new methods for CRC diagnosis, treatment, and prognosis assessment.

Citing Articles

LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis.

Masrour M, Khanmohammadi S, Habibzadeh A, Fallahtafti P PLoS One. 2024; 19(10):e0308009.

PMID: 39471147 PMC: 11521308. DOI: 10.1371/journal.pone.0308009.


Anti-angiogenesis in colorectal cancer therapy.

Yang Z, Zhang X, Bai X, Xi X, Liu W, Zhong W Cancer Sci. 2024; 115(3):734-751.

PMID: 38233340 PMC: 10921012. DOI: 10.1111/cas.16063.


MBNL1‑AS1 attenuates tumor cell proliferation by regulating the miR‑29c‑3p/BVES signal in colorectal cancer.

Chen W, Zhang X, Zhao Z, Che X Oncol Rep. 2023; 50(4).

PMID: 37711058 PMC: 10523431. DOI: 10.3892/or.2023.8628.


Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review.

Moslehian M, Shabkhizan R, Asadi M, Bazmani A, Mahdipour M, Haiaty S BMC Cancer. 2023; 23(1):512.

PMID: 37280524 PMC: 10243085. DOI: 10.1186/s12885-023-11008-9.


Analysis of LINC01314 and miR-96 Expression in Colorectal Cancer Patients via Tissue Microarray-Based Fluorescence Hybridization.

Zhang R, Zhang G, Li B, Wang J, Wang J, Che J Dis Markers. 2022; 2022:5378963.

PMID: 36246563 PMC: 9568347. DOI: 10.1155/2022/5378963.


References
1.
Wang W, Martindale J, Yang X, Chrest F, Gorospe M . Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 2005; 6(2):158-64. PMC: 1299256. DOI: 10.1038/sj.embor.7400346. View

2.
Na H, Surh Y . Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic Biol Med. 2013; 67:353-65. DOI: 10.1016/j.freeradbiomed.2013.10.819. View

3.
Chase A, Cross N . Aberrations of EZH2 in cancer. Clin Cancer Res. 2011; 17(9):2613-8. DOI: 10.1158/1078-0432.CCR-10-2156. View

4.
Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L . Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. Nucleic Acids Res. 2018; 46(11):5809-5821. PMC: 6009600. DOI: 10.1093/nar/gky214. View

5.
Doherty J, Cleveland J . Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013; 123(9):3685-92. PMC: 3754272. DOI: 10.1172/JCI69741. View